Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Open in Screener

ACVA

ACV Auctions Inc

May 17 • 04:00PM ET

18.62

Dollar change +0.39
Percentage change 2.14	%

Consumer Cyclical • Auto & Truck Dealerships • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI VB IWM VXF VBK IWO SCHA VTWO DFAS DWAS

Index	RUT	P/E	-	EPS (ttm)	-0.48	Insider Own	12.74%	Shs Outstand	165.09M	Perf Week	7.69%
Market Cap	3.07B	Forward P/E	45.78	EPS next Y	0.41	Insider Trans	-15.49%	Shs Float	144.05M	Perf Month	7.63%
Income	-77.53M	PEG	-	EPS next Q	0.02	Inst Own	87.33%	Short Float	6.45%	Perf Quarter	30.30%
Sales	507.30M	P/S	6.06	EPS this Y	130.38%	Inst Trans	4.02%	Short Ratio	7.23	Perf Half Y	18.45%
Book/sh	2.78	P/B	6.69	EPS next Y	1244.45%	ROA	-7.60%	Short Interest	9.29M	Perf Year	10.44%
Cash/sh	2.07	P/C	9.00	EPS next 5Y	0.80%	ROE	-16.51%	52W Range	12.84 - 19.54	Perf YTD	22.90%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-15.18%	ROI	-12.67%	52W High	-4.71%	Beta	1.55
Dividend TTM	-	Quick Ratio	1.62	Sales past 5Y	79.89%	Gross Margin	45.40%	52W Low	45.02%	ATR (14)	0.79
Dividend Ex-Date	-	Current Ratio	1.62	EPS Y/Y TTM	16.48%	Oper. Margin	-17.16%	RSI (14)	57.03	Volatility	4.36% 4.13%
Employees	2170	Debt/Eq	0.34	Sales Y/Y TTM	15.80%	Profit Margin	-15.28%	Recom	1.46	Target Price	22.00
Option/Short	Yes / Yes	LT Debt/Eq	0.34	EPS Q/Q	-9.59%	Payout	-	Rel Volume	0.94	Prev Close	18.23
Sales Surprise	1.22%	EPS Surprise	-68.32%	Sales Q/Q	21.79%	Earnings	May 08 AMC	Avg Volume	1.29M	Price	18.62
SMA20	5.00%	SMA50	3.55%	SMA200	18.23%	Trades		Volume	1,202,378	Change	2.14%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-10-24	Upgrade	Northcoast	Neutral → Buy	$22
Jul-20-23	Initiated	B. Riley Securities	Buy	$23
Jul-13-23	Downgrade	JP Morgan	Overweight → Neutral	$17
Feb-16-23	Downgrade	Piper Sandler	Overweight → Neutral	$11
Jun-30-22	Resumed	JMP Securities	Mkt Outperform
Jun-10-22	Initiated	Barrington Research	Outperform	$18
Apr-20-22	Resumed	Citigroup	Buy	$20
Mar-02-22	Upgrade	Stephens	Equal-Weight → Overweight	$17 → $19
Mar-01-22	Initiated	Needham	Buy	$20
Jan-07-22	Initiated	Goldman	Buy	$26
Oct-29-21	Initiated	Truist	Buy	$30
Aug-23-21	Upgrade	Citigroup	Neutral → Buy	$29 → $23
Aug-18-21	Upgrade	Piper Sandler	Neutral → Overweight	$30 → $26
Aug-13-21	Upgrade	BofA Securities	Neutral → Buy	$33 → $35
Aug-04-21	Upgrade	JP Morgan	Neutral → Overweight	$30
Apr-19-21	Initiated	Raymond James	Mkt Perform
Apr-19-21	Initiated	Piper Sandler	Neutral	$36
Apr-19-21	Initiated	JP Morgan	Neutral	$30
Apr-19-21	Initiated	JMP Securities	Mkt Outperform	$45
Apr-19-21	Initiated	Jefferies	Buy	$45

Show Previous Ratings

May-16-24 04:17PM	Acv Auctions Insider Sold Shares Worth $574,925, According to a Recent SEC Filing (MT Newswires)
May-14-24 06:11AM	Q1 2024 Rand Capital Corp Earnings Call (Thomson Reuters StreetEvents)
03:02AM	Rand Capital Corp (RAND) (Q1 2024) Earnings Call Transcript Highlights: Strategic Shifts and ... (GuruFocus.com)
May-10-24 05:44PM	ACV Auctions Inc. (NASDAQ:ACVA) Q1 2024 Earnings Call Transcript (Insider Monkey)
01:00PM	ACV Auctions Inc. Reports First Quarter 2024 Results: Revenue Growth Surpasses Estimates (GuruFocus.com)
10:08AM	Loading…
May-09-24 10:08AM	Piper Sandler Adjusts Price Target on ACV Auctions to $16 From $15, Maintains Neutral Rating (MT Newswires)
09:23AM	Q1 2024 ACV Auctions Inc Earnings Call (Thomson Reuters StreetEvents)
08:41AM	B. Riley Adjusts Price Target on ACV Auctions to $24 From $23, Maintains Buy Rating (MT Newswires)
08:00AM	ACV to Participate in Upcoming Investor Conferences (GlobeNewswire)
04:02AM	ACV Auctions Inc (ACVA) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations ... (GuruFocus.com)
May-08-24 10:56PM	ACVA Stock Earnings: ACV Auctions Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:30PM	ACV Auctions (ACVA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:55PM	ACV Auctions Inc. (ACVA) Reports Break-Even Earnings for Q1 (Zacks)
04:35PM	ACV Auctions (NASDAQ:ACVA) Posts Better-Than-Expected Sales In Q1 But Quarterly Guidance Underwhelms (StockStory)
04:05PM	ACV's Data-Driven Solutions Drive Profits and Optimize Inventory for Dealerships (GlobeNewswire)
04:05PM	Loading…
04:05PM	ACV Announces First Quarter 2024 Results (GlobeNewswire)
May-07-24 03:03AM	What To Expect From ACV Auctions's (ACVA) Q1 Earnings (StockStory)
May-06-24 09:16AM	Countdown to ACV Auctions (ACVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Apr-26-24 07:00AM	Used-Car Sales Have Moved OnlineHeres Why Both Customers and Dealers Are Happy (The Wall Street Journal)
Apr-24-24 04:05PM	ACV to Report First Quarter 2024 Financial Results on May 8, 2024 (GlobeNewswire)
Apr-15-24 08:05AM	ACV Transportation Expands Services to Vehicles Purchased Outside of the ACV Platform (GlobeNewswire)
Apr-05-24 07:00PM	Insider Sell: COO Vikas Mehta Sells 121,741 Shares of ACV Auctions Inc (ACVA) (GuruFocus.com)
Apr-04-24 01:31AM	Insider Sell: COO Vikas Mehta Sells 78,259 Shares of ACV Auctions Inc (ACVA) (GuruFocus.com)
Apr-02-24 08:03AM	Does ACV Auctions (ACVA) Have the Potential to Create a Strong Competitive Moat? (Insider Monkey)
Mar-22-24 01:53AM	ACV Auctions Inc CFO William Zerella Sells 32,500 Shares (GuruFocus.com)
01:53AM	ACV Auctions Inc CEO George Chamoun Sells Over 300,000 Shares (GuruFocus.com)
Mar-20-24 08:29PM	Fuel Me Secures $18 Million in Oversubscribed Series A to Redefine Fuel Procurement as We Know It (PR Newswire)
Feb-28-24 08:00AM	ACV to Participate in The Citizens JMP Technology Conference (GlobeNewswire)
Feb-27-24 08:19AM	ACV Auctions Inc. (NASDAQ:ACVA) Q4 2023 Earnings Call Transcript (Insider Monkey) +7.14%
Feb-23-24 04:05PM	Carvana Stock Soars With Earnings Outlook Seen 'Driving The Squeeze' (Investor's Business Daily)
12:51PM	Loading…
12:51PM	Carvana Stock Drives Past Buy Point As Earnings Outlook 'Trumps' Mixed Report (Investor's Business Daily)
11:00AM	Carvana Stock Soars Above Buy Point As Earnings Outlook 'Trumps' Mixed Report (Investor's Business Daily)
Feb-22-24 05:56PM	Carvana Stock Soars As Online Used-Car Seller Guides High (Investor's Business Daily) +17.21%
05:56PM	Why ACV Auctions Stock Popped Today (Motley Fool)
04:50PM	Carvana Stock Soars After Guiding Higher Used Car Sales, Earnings In 2024 (Investor's Business Daily)
04:05PM	Carvana Stock Pops With Earnings On Deck. A Used-Car Auction Peer Soars. (Investor's Business Daily)
01:16PM	Carvana Stock Rises With Earnings On Deck. A Used-Car Auction Peer Beats And Soars. (Investor's Business Daily)
07:53AM	Q4 2023 ACV Auctions Inc Earnings Call (Thomson Reuters StreetEvents)
05:00AM	7 Unstoppable Software Stocks Set to Soar in 2024 (InvestorPlace)
Feb-21-24 06:30PM	ACV Auctions Inc. (ACVA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:50PM	ACV Auctions Inc. (ACVA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	ACV Auctions Announces the Settlement of Litigation Regarding AutoIMS (GlobeNewswire)
04:05PM	ACV Announces Fourth Quarter and Full-Year 2023 Results (GlobeNewswire)
Feb-19-24 09:15AM	ACV Auctions Inc. (ACVA) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures (Zacks)
Feb-09-24 01:40AM	ACV Auctions Inc CFO William Zerella Sells 32,500 Shares (GuruFocus.com)
Feb-07-24 07:09AM	Baron Discovery Fund Sold ACV Auctions (ACVA) Due to the Current Valuation (Insider Monkey)
Feb-02-24 05:00AM	3 Growth Stocks Poised for a 2024 Millionaire-Making Moonshot (InvestorPlace)
Feb-01-24 09:15AM	Impel Launches Car Buying AI and Integrates with ACV Auctions' ClearCar to Bring Enhanced Inventory Acquisition Solution to Auto Dealers (PR Newswire)
Jan-24-24 04:05PM	ACV to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024 (GlobeNewswire)
Jan-18-24 04:30PM	Tyler Hall Joins Signal Technologies as Chief Commercial Officer (PR Newswire)
Jan-12-24 01:03AM	ACV Auctions Inc CFO William Zerella Sells 32,500 Shares (GuruFocus.com)
Jan-11-24 08:30AM	ACV to Showcase the Future of Vehicle Sourcing and Inventory Management at the 2024 National Automobile Dealers Association Show in Las Vegas (GlobeNewswire)
Dec-17-23 04:51AM	5 Most Promising Car Stocks According to Analysts (Insider Monkey)
Dec-16-23 01:12PM	Insider Sell: CEO George Chamoun Sells 443,776 Shares of ACV Auctions Inc (ACVA) (GuruFocus.com)
Dec-15-23 01:02PM	Insider Sell: CFO William Zerella Sells 17,500 Shares of ACV Auctions Inc (ACVA) (GuruFocus.com) -5.28%
Dec-12-23 09:40AM	Is ACV Auctions (ACVA) Outperforming Other Retail-Wholesale Stocks This Year? (Zacks) -6.12%
Nov-23-23 09:40AM	Are Retail-Wholesale Stocks Lagging ACV Auctions (ACVA) This Year? (Zacks)
Nov-22-23 09:55AM	Wall Street Analysts See a 31.71% Upside in ACV Auctions Inc. (ACVA): Can the Stock Really Move This High? (Zacks)
Nov-17-23 11:22AM	ACV Panels Discuss using AI for Trusted Vehicle Valuation and Disposal Strategies at Used Car Week 2023 (GlobeNewswire)
09:04AM	Insider Sell: CFO William Zerella Sells 17,500 Shares of ACV Auctions Inc (ACVA) (GuruFocus.com)
Nov-07-23 09:46AM	ACV Auctions Inc. (NASDAQ:ACVA) Q3 2023 Earnings Call Transcript (Insider Monkey)
08:30AM	ACV Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
Nov-06-23 05:30PM	Compared to Estimates, ACV Auctions Inc. (ACVA) Q3 Earnings: A Look at Key Metrics (Zacks)
05:11PM	ACV Auctions Inc (ACVA) Q3 2023 Earnings: Revenue Up 13% YoY, Adjusted EBITDA Beats Guidance (GuruFocus.com)
04:01PM	ACV Announces Third Quarter 2023 Results (GlobeNewswire)
09:55AM	Wall Street Analysts Think ACV Auctions Inc. (ACVA) Could Surge 39.09%: Read This Before Placing a Bet (Zacks)
Oct-30-23 10:00AM	Will ACV Auctions Inc. (ACVA) Report Negative Earnings Next Week? What You Should Know (Zacks)
Oct-19-23 09:40AM	Are Retail-Wholesale Stocks Lagging ACV Auctions (ACVA) This Year? (Zacks)
Oct-16-23 04:05PM	ACV to Report Third Quarter 2023 Financial Results on November 6, 2023 (GlobeNewswire)
08:30AM	ACV Leverages AI to Introduce ClearCar (GlobeNewswire)
Oct-12-23 11:01PM	Insider Sell: CFO William Zerella Sells 17,500 Shares of ACV Auctions Inc (ACVA) (GuruFocus.com)
Sep-29-23 09:40AM	Is ACV Auctions (ACVA) Stock Outpacing Its Retail-Wholesale Peers This Year? (Zacks)
Sep-25-23 03:48AM	ACV Auctions (ACVA) Rose on Full-Year Guidance (Insider Monkey)
Sep-15-23 07:20PM	Insider Sell: CEO George Chamoun Sells 245,474 Shares of ACV Auctions Inc (ACVA) (GuruFocus.com)
Sep-14-23 07:11PM	Insider Sell: Craig Anderson Sells 15,000 Shares of ACV Auctions Inc (ACVA) (GuruFocus.com)
Sep-12-23 09:40AM	Is ACV Auctions (ACVA) Outperforming Other Retail-Wholesale Stocks This Year? (Zacks)
Aug-30-23 09:00AM	ACV Prioritizes User Experience and Customer Communication Enhancements, Adding Chat to Its Robust Options (GlobeNewswire)
Aug-23-23 04:05PM	ACV Announces Participation in Upcoming Investor Conferences (GlobeNewswire)
Aug-08-23 10:48AM	Q2 2023 ACV Auctions Inc Earnings Call (Thomson Reuters StreetEvents)
09:27AM	ACV Auctions Inc. (NASDAQ:ACVA) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-07-23 04:05PM	ACV Announces Second Quarter 2023 Results (GlobeNewswire)
Aug-05-23 12:38AM	Q2 2023 Rand Capital Corp Earnings Call (Thomson Reuters StreetEvents)
Jul-27-23 07:20AM	ACV Auctions Inc. (NASDAQ:ACVA) Shares Could Be 45% Below Their Intrinsic Value Estimate (Simply Wall St.)
Jul-17-23 04:05PM	ACV to Report Second Quarter 2023 Financial Results and Participate in the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Jul-13-23 10:00AM	Best Momentum Stocks to Buy for July 13 (Zacks)
Jun-29-23 09:40AM	Has ACV Auctions (ACVA) Outpaced Other Retail-Wholesale Stocks This Year? (Zacks)
Jun-28-23 09:05AM	When Will ACV Auctions Inc. (NASDAQ:ACVA) Become Profitable? (Simply Wall St.)
Jun-22-23 05:00AM	Zacks Industry Outlook Highlights PDD Holdings, Rover Group and ACV Auctions (Zacks)
Jun-21-23 03:54PM	3 Picks from a Strengthening E-commerce Industry (Zacks)
Jun-13-23 09:40AM	Are Retail-Wholesale Stocks Lagging ACV Auctions (ACVA) This Year? (Zacks)
Jun-08-23 09:30AM	ACVs 2023 Analyst Day Showcases Latest Data & Technology Innovations (GlobeNewswire)
May-26-23 09:40AM	Is ACV Auctions (ACVA) Stock Outpacing Its Retail-Wholesale Peers This Year? (Zacks)
May-11-23 07:02PM	Why ACV Auctions Stock Trounced the Market Today (Motley Fool) +20.42%
May-10-23 06:35PM	ACV Auctions Inc. (ACVA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	ACV Announces First Quarter 2023 Results (GlobeNewswire)
02:19AM	Q1 2023 Rand Capital Corp Earnings Call (Thomson Reuters StreetEvents)
May-08-23 06:13AM	Is It Time To Consider Buying ACV Auctions Inc. (NASDAQ:ACVA)? (Simply Wall St.)
Apr-19-23 04:05PM	ACV to Report First Quarter 2023 Financial Results on May 10, 2023 (GlobeNewswire)
Apr-17-23 09:15AM	ACV Auctions Inc. (NASDAQ:ACVA) Investors Are Less Pessimistic Than Expected (Simply Wall St.)
Mar-31-23 09:13AM	ACV Reaches Milestone Of Over Three Million Vehicle Inspections and Two Million Vehicles Sold, Extending Its Data Moat and Marketplace Share Gains (GlobeNewswire)

ACV Auctions, Inc. provides a vibrant digital marketplace for wholesale vehicle transactions and data services, which offers transparent and accurate vehicle information to its customers. The company's platform leverages data insights and technology to power its digital marketplace and data services, enabling its dealers and commercial partners to buy, sell and value vehicles. Its platform includes Digital Marketplace, Remarketing Centers, Data Services and Data and Technology. Digital Marketplace connects buyers and sellers of wholesale vehicles in an intuitive and efficient manner. Remarketing Centers provides an additional channel to provide dealers and commercial partners with auction services. Data Services offers insights into the condition and value of used vehicles for transactions both on and off its marketplace and helps dealers, their end consumers, and commercial partners make more informed decisions to transact with confidence and efficiency. Data and Technology underpins everything it does, and powers its vehicle inspections, comprehensive vehicle intelligence reports, digital marketplace and operations automation platform. The company was founded by Joseph Neiman, Daniel Magnuszewsk, and Jack Greco in December 2014 and is headquartered in Buffalo, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ZERELLA WILLIAM	Chief Financial Officer	May 14 '24	Sale	17.69	32,500	574,925	314,151	May 16 04:14 PM
ZERELLA WILLIAM	Chief Financial Officer	Apr 16 '24	Sale	17.17	32,500	558,025	314,151	Apr 17 05:20 PM
Anderson Craig Eric	CCDSO	Apr 09 '24	Sale	18.50	7,500	138,750	194,525	Apr 11 04:09 PM
Mehta Vikas	Chief Operating Officer	Apr 04 '24	Sale	18.55	13,399	248,551	321,475	Apr 05 04:12 PM
Mehta Vikas	Chief Operating Officer	Apr 03 '24	Sale	18.40	108,342	1,993,493	321,475	Apr 05 04:12 PM
Mehta Vikas	Chief Operating Officer	Apr 02 '24	Sale	17.97	78,259	1,406,314	321,475	Apr 03 05:36 PM
Anderson Craig Eric	CCDSO	Mar 28 '24	Sale	19.07	5,000	95,350	202,797	Mar 29 04:01 PM
Chamoun George	Chief Executive Officer	Mar 21 '24	Sale	19.14	120,062	2,297,987	597,921	Mar 21 07:32 PM
Chamoun George	Chief Executive Officer	Mar 20 '24	Sale	18.73	77,198	1,445,919	597,921	Mar 21 07:32 PM
Chamoun George	Chief Executive Officer	Mar 19 '24	Sale	18.42	124,999	2,302,482	597,921	Mar 21 07:32 PM
ZERELLA WILLIAM	Chief Financial Officer	Mar 19 '24	Sale	18.40	32,500	598,000	323,286	Mar 21 07:26 PM
Hirsch Brian	Director	Mar 15 '24	Sale	17.58	3,362	59,104	0	Mar 15 05:36 PM
Hirsch Brian	Director	Mar 14 '24	Sale	17.38	102,970	1,789,619	3,362	Mar 15 05:36 PM
KAMERICK EILEEN A	Director	Mar 14 '24	Sale	17.34	12,498	216,715	0	Mar 18 05:20 PM
Hirsch Brian	Director	Mar 13 '24	Sale	17.49	1,101,807	19,270,604	0	Mar 15 05:36 PM
Hirsch Brian	Director	Mar 13 '24	Sale	17.67	61,853	1,092,943	106,332	Mar 15 05:36 PM
Hirsch Brian	Director	Mar 12 '24	Sale	17.52	79,174	1,387,128	275,452	Mar 13 07:15 PM
Hirsch Brian	Director	Mar 11 '24	Sale	17.46	24,052	419,948	295,245	Mar 13 07:15 PM
Hirsch Brian	Director	Mar 08 '24	Sale	18.31	241,455	4,421,041	301,258	Mar 08 06:15 PM
Hirsch Brian	Director	Mar 07 '24	Sale	17.96	67,072	1,204,613	361,622	Mar 08 06:15 PM
Hirsch Brian	Director	Mar 06 '24	Sale	18.24	38,763	707,037	378,390	Mar 08 06:15 PM
Mehta Vikas	Chief Operating Officer	Mar 06 '24	Sale	18.67	9,003	168,086	333,327	Mar 07 05:13 PM
Mehta Vikas	Chief Operating Officer	Mar 05 '24	Sale	18.62	333,497	6,209,714	333,327	Mar 07 05:13 PM
ZERELLA WILLIAM	Chief Financial Officer	Mar 05 '24	Sale	18.72	50,000	936,000	323,286	Mar 07 05:11 PM
Waterman Michael	Chief Sales Officer	Mar 05 '24	Sale	18.47	10,130	187,101	234,234	Mar 07 05:12 PM
Anderson Craig Eric	CCDSO	Feb 28 '24	Sale	18.00	5,000	90,000	202,797	Feb 29 05:00 PM
Mehta Vikas	Chief Operating Officer	Feb 22 '24	Sale	16.48	200,000	3,296,000	319,036	Feb 26 06:09 PM
ZERELLA WILLIAM	Chief Financial Officer	Feb 06 '24	Sale	14.07	32,500	457,275	305,579	Feb 08 05:02 PM
ZERELLA WILLIAM	Chief Financial Officer	Jan 09 '24	Sale	13.55	32,500	440,375	305,579	Jan 11 04:15 PM
Waterman Michael	Chief Sales Officer	Jan 09 '24	Sale	13.54	4,919	66,603	219,963	Jan 11 04:19 PM
Anderson Craig Eric	CCDSO	Jan 03 '24	Sale	14.43	48,297	696,926	191,526	Jan 04 06:50 PM
Anderson Craig Eric	CCDSO	Jan 02 '24	Sale	14.89	129,552	1,929,029	199,781	Jan 04 06:50 PM
Anderson Craig Eric	CCDSO	Dec 21 '23	Sale	14.97	58,883	881,479	199,413	Dec 21 06:55 PM
Anderson Craig Eric	CCDSO	Dec 20 '23	Sale	14.72	73,016	1,074,796	199,413	Dec 21 06:55 PM
Anderson Craig Eric	CCDSO	Dec 19 '23	Sale	14.86	40,252	598,145	199,413	Dec 21 06:55 PM
Chamoun George	Chief Executive Officer	Dec 15 '23	Sale	14.65	190,471	2,790,400	599,293	Dec 15 05:23 PM
Chamoun George	Chief Executive Officer	Dec 14 '23	Sale	15.29	128,691	1,967,685	599,293	Dec 15 05:23 PM
Chamoun George	Chief Executive Officer	Dec 13 '23	Sale	14.32	124,614	1,784,472	599,293	Dec 15 05:23 PM
ZERELLA WILLIAM	Chief Financial Officer	Dec 12 '23	Sale	13.70	17,500	239,750	315,296	Dec 14 04:21 PM
ZERELLA WILLIAM	Chief Financial Officer	Nov 14 '23	Sale	14.68	17,500	256,900	315,296	Nov 16 04:15 PM
ZERELLA WILLIAM	Chief Financial Officer	Oct 10 '23	Sale	15.08	17,500	263,900	315,296	Oct 12 04:16 PM
Waterman Michael	Chief Sales Officer	Oct 04 '23	Sale	14.60	5,210	76,066	228,762	Oct 05 04:35 PM
Chamoun George	Chief Executive Officer	Sep 14 '23	Sale	15.74	64,383	1,013,388	622,950	Sep 14 06:51 PM
Bessemer Venture Partners IX L	10% Owner	Sep 14 '23	Sale	15.80	39,073	617,353	1,814,592	Sep 19 06:59 PM
Chamoun George	Chief Executive Officer	Sep 13 '23	Sale	15.61	97,196	1,517,230	622,950	Sep 14 06:51 PM
Bessemer Venture Partners IX L	10% Owner	Sep 13 '23	Sale	16.07	5,549	89,172	1,853,665	Sep 15 06:10 AM
Bessemer Venture Partners IX L	10% Owner	Sep 12 '23	Sale	16.21	128,479	2,082,645	1,859,214	Sep 15 06:10 AM
Chamoun George	Chief Executive Officer	Sep 12 '23	Sale	16.21	83,895	1,359,938	622,950	Sep 14 06:51 PM
Mehta Vikas	Chief Operating Officer	Sep 12 '23	Sale	16.21	50,000	810,500	342,577	Sep 14 04:34 PM
ZERELLA WILLIAM	Chief Financial Officer	Sep 12 '23	Sale	16.21	17,500	283,675	324,432	Sep 14 06:49 PM
Anderson Craig Eric	CCDSO	Sep 12 '23	Sale	16.21	15,000	243,150	207,684	Sep 14 04:37 PM
ZERELLA WILLIAM	Chief Financial Officer	Aug 15 '23	Sale	15.73	17,500	275,275	324,432	Aug 16 05:31 PM
Castillo Kirsten	Director	Aug 11 '23	Sale	15.69	30,000	470,700	0	Aug 15 04:22 PM
Waterman Michael	Chief Sales Officer	Jul 25 '23	Sale	16.66	6,043	100,676	237,569	Jul 27 04:16 PM
Waterman Michael	Chief Sales Officer	Jul 12 '23	Sale	18.05	5,410	97,650	239,532	Jul 13 04:12 PM
ZERELLA WILLIAM	Chief Financial Officer	Jul 11 '23	Sale	17.29	17,500	302,575	324,432	Jul 13 04:15 PM
Waterman Michael	Chief Sales Officer	Jul 11 '23	Sale	17.26	5,410	93,377	241,224	Jul 13 04:12 PM
Chamoun George	Chief Executive Officer	Jun 22 '23	Sale	17.75	105,970	1,880,968	646,607	Jun 22 05:30 PM
Chamoun George	Chief Executive Officer	Jun 21 '23	Sale	17.83	101,041	1,801,561	646,607	Jun 22 05:30 PM
Chamoun George	Chief Executive Officer	Jun 20 '23	Sale	18.01	143,049	2,576,312	646,607	Jun 22 05:30 PM
ZERELLA WILLIAM	Chief Financial Officer	Jun 20 '23	Sale	17.93	17,500	313,775	333,567	Jun 22 04:30 PM
Hirsch Brian	Director	Jun 16 '23	Sale	18.00	7,373	132,714	182,647	Jun 20 04:39 PM
Bessemer Venture Partners IX L	10% Owner	Jun 15 '23	Sale	17.90	73,951	1,323,723	0	Jun 20 04:05 PM
Hirsch Brian	Director	Jun 15 '23	Sale	17.81	60,394	1,075,617	190,020	Jun 20 04:39 PM
Hirsch Brian	Director	Jun 14 '23	Sale	17.66	46,195	815,804	0	Jun 14 06:14 PM
Hirsch Brian	Director	Jun 14 '23	Sale	17.69	25,702	454,668	250,414	Jun 14 06:14 PM
Waterman Michael	Chief Sales Officer	Jun 14 '23	Sale	17.66	23,482	414,692	250,032	Jun 15 04:27 PM
Bessemer Venture Partners IX L	10% Owner	Jun 13 '23	Sale	18.09	74,552	1,348,646	74,951	Jun 13 08:08 PM
Hirsch Brian	Director	Jun 13 '23	Sale	18.02	63,322	1,141,062	0	Jun 14 06:14 PM
Hirsch Brian	Director	Jun 13 '23	Sale	18.03	56,710	1,022,481	276,116	Jun 14 06:14 PM
Mehta Vikas	Chief Operating Officer	Jun 13 '23	Sale	18.00	50,000	900,000	354,429	Jun 15 04:23 PM
Anderson Craig Eric	CCDSO	Jun 13 '23	Sale	18.00	15,000	270,000	215,956	Jun 15 04:20 PM
Hirsch Brian	Director	Jun 12 '23	Sale	18.02	84,076	1,515,050	0	Jun 14 06:14 PM
Bessemer Venture Partners IX L	10% Owner	Jun 12 '23	Sale	18.07	83,473	1,508,357	149,503	Jun 13 08:08 PM
Bessemer Venture Partners IX L	10% Owner	Jun 09 '23	Sale	18.22	92,405	1,683,619	232,976	Jun 13 08:08 PM
Bessemer Venture Partners IX L	10% Owner	Jun 08 '23	Sale	18.22	342,236	6,235,540	325,381	Jun 08 08:12 PM
Bessemer Venture Partners IX L	10% Owner	Jun 07 '23	Sale	18.12	30,338	549,725	667,617	Jun 08 08:12 PM
Bessemer Venture Partners IX L	10% Owner	Jun 06 '23	Sale	18.02	295,891	5,331,956	697,955	Jun 08 08:12 PM
KAMERICK EILEEN A	Director	May 25 '23	Sale	17.21	25,000	430,250	0	May 26 04:47 PM
Castillo Kirsten	Director	May 24 '23	Sale	17.34	36,583	634,349	0	May 26 04:48 PM

Open in Screener

OCGN

Ocugen Inc

May 17 • 04:00PM ET

1.91

Dollar change -0.07
Percentage change -3.54	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF VHT ITOT GERM AVSC

Index	-	P/E	-	EPS (ttm)	-0.24	Insider Own	2.19%	Shs Outstand	256.57M	Perf Week	20.13%
Market Cap	491.50M	Forward P/E	-	EPS next Y	-0.29	Insider Trans	0.00%	Shs Float	251.69M	Perf Month	44.70%
Income	-59.98M	PEG	-	EPS next Q	-0.05	Inst Own	12.76%	Short Float	19.03%	Perf Quarter	101.24%
Sales	2.42M	P/S	203.10	EPS this Y	16.67%	Inst Trans	-2.90%	Short Ratio	4.60	Perf Half Y	403.16%
Book/sh	0.12	P/B	16.24	EPS next Y	-35.38%	ROA	-81.00%	Short Interest	47.89M	Perf Year	175.93%
Cash/sh	0.10	P/C	18.63	EPS next 5Y	-	ROE	-113.11%	52W Range	0.34 - 2.11	Perf YTD	232.17%
Dividend Est.	-	P/FCF	-	EPS past 5Y	41.20%	ROI	-170.36%	52W High	-9.26%	Beta	3.63
Dividend TTM	-	Quick Ratio	1.87	Sales past 5Y	8.52%	Gross Margin	65.21%	52W Low	453.62%	ATR (14)	0.18
Dividend Ex-Date	-	Current Ratio	1.87	EPS Y/Y TTM	33.96%	Oper. Margin	-2595.87%	RSI (14)	62.30	Volatility	11.74% 11.60%
Employees	65	Debt/Eq	0.23	Sales Y/Y TTM	-	Profit Margin	-2475.48%	Recom	1.00	Target Price	6.67
Option/Short	Yes / Yes	LT Debt/Eq	0.16	EPS Q/Q	36.61%	Payout	-	Rel Volume	0.62	Prev Close	1.98
Sales Surprise	-	EPS Surprise	21.01%	Sales Q/Q	-	Earnings	May 14 BMO	Avg Volume	10.42M	Price	1.91
SMA20	28.06%	SMA50	31.33%	SMA200	158.86%	Trades		Volume	6,431,914	Change	-3.54%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-01-23	Upgrade	Chardan Capital Markets	Neutral → Buy	$3.50
Aug-23-22	Initiated	Mizuho	Buy	$5
Jun-15-22	Resumed	ROTH Capital	Buy	$8
Jun-02-22	Initiated	Cantor Fitzgerald	Overweight	$4.50
Jul-26-21	Initiated	Noble Capital Markets	Outperform
Jun-11-21	Downgrade	ROTH Capital	Buy → Neutral	$10 → $6
May-07-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Feb-09-21	Downgrade	Chardan Capital Markets	Buy → Neutral	$0.70 → $13
Feb-04-21	Upgrade	H.C. Wainwright	Neutral → Buy	$4.50

May-15-24 07:30AM	Ocugen Completes Dosing of Second Group in Stargardt Eye Therapy Safety and Efficacy Study (MT Newswires) +15.29%
06:30AM	Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST A Modifier Gene Therapy (GlobeNewswire)
03:02AM	Ocugen Inc (OCGN) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances Amid ... (GuruFocus.com)
01:12AM	Q1 2024 Ocugen Inc Earnings Call (Thomson Reuters StreetEvents)
May-14-24 11:53AM	OCGN Stock Earnings: Ocugen Beats EPS for Q1 2024 (InvestorPlace) -6.08%
08:00AM	Loading…
08:00AM	Ocugen Provides Business Update with First Quarter 2024 Financial Results (GlobeNewswire)
06:43AM	Ocugen: Q1 Earnings Snapshot (Associated Press Finance)
May-10-24 04:05PM	Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock (GlobeNewswire)
07:45AM	Ocugen to Present at May 2024 Investor Conferences (GlobeNewswire)
May-08-24 06:00AM	Millionaire Blueprint: 3 Stocks Under $5 With Massive Growth Potential by 2028 (InvestorPlace) +9.55%
May-03-24 07:30AM	Ocugen to Host Conference Call on Tuesday, May 14 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 07:15AM	Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress (GlobeNewswire) -5.04%
Apr-29-24 08:30AM	Can Ocugen Stock Keep Churning Higher? (Motley Fool) +8.59%
06:45AM	Ocugen Announces OCU400 Modifier Gene Therapy Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024 (GlobeNewswire)
Apr-28-24 11:59AM	5 ChatGPT Penny Stock Picks Right Now (Insider Monkey)
12:35PM	Loading…
Apr-26-24 12:35PM	Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards? (Zacks) +8.47%
09:05AM	UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting (GlobeNewswire)
06:30AM	Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting (GlobeNewswire)
Apr-19-24 07:13AM	Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410-A Modifier Gene Therapy (GlobeNewswire)
Apr-16-24 10:53PM	OCGN Stock Earnings: Ocugen Beats EPS for Q4 2023 (InvestorPlace)
Apr-12-24 07:30AM	Ocugen to Participate in Fireside Chat at the Emerging Growth Virtual Healthcare Equity Conference, Presented by Noble Capital Markets (GlobeNewswire)
Apr-10-24 07:02AM	Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU400 Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication (GlobeNewswire) +5.26%
Apr-08-24 12:13PM	Ocugen (OCGN) Up as DSMB Allows Cohort 2 Dosing in GA Study (Zacks)
10:57AM	Why Is Ocugen (OCGN) Stock Up 7% Today? (InvestorPlace)
06:30AM	Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial First Gene Therapy to Enter Phase 3 with a Broad Retinitis Pigmentosa Indication (GlobeNewswire)
Apr-05-24 03:30PM	OCGN Stock Alert: Why Is Ocugen Up 20% Today? (InvestorPlace) +21.19%
07:02AM	Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410 a Modifier Gene Therapy in Phase 1/2 ArMaDa Study for Geographic Atrophy (GlobeNewswire)
Apr-02-24 10:50PM	Q4 2023 Ocugen Inc Earnings Call (Thomson Reuters StreetEvents) -10.39%
07:00PM	Ocugen (OCGN) Q4 2023 Earnings Call Transcript (Motley Fool)
03:15PM	OCGN Stock Falls Ocugen Must Restate Its Financials (InvestorPlace)
08:00AM	Loading…
08:00AM	Ocugen Provides Business Update with Certain Financials for the Year Ending 2023 (GlobeNewswire)
Apr-01-24 06:08PM	Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410ST a Modifier Gene Therapy in GARDian Study for Stargardt Disease (GlobeNewswire) -6.10%
05:43PM	Ocugen to Host Conference Call on Tuesday, April 2 at 8:30 A.M. ET to Provide Business Update with Certain Financials for the Year Ending 2023 (GlobeNewswire)
Mar-25-24 11:58AM	Why Is Ocugen (OCGN) Stock Up 20% Today? (InvestorPlace) +11.59%
07:32AM	3 Stocks Under $5 Ready to Outpace the Market (InvestorPlace)
Mar-18-24 06:30AM	Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical Officer (GlobeNewswire)
Mar-13-24 08:00AM	Ocugen, Inc. Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410 (GlobeNewswire) +5.69%
Mar-07-24 05:28AM	Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street (Motley Fool) +16.09%
Mar-06-24 07:30AM	Ocugen to Present at Investing in Cures Summit (GlobeNewswire)
Feb-28-24 08:00AM	Ocugen Clinical Showcase Webcast Now Available (GlobeNewswire)
Feb-26-24 04:34PM	Meme Stock Meltdowns: 3 Names to Sell Before They Crash (InvestorPlace) +13.28%
08:30AM	Ocugen Chairman and CEO to present at Abu Dhabi Family Office Summit (GlobeNewswire)
Feb-22-24 04:05PM	Ocugen, Inc. Announces Dosing Completion of Subjects with Stargardt in Cohort 1 of Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST (GlobeNewswire) -5.98%
12:56PM	5 Hot Penny Stock On the Move (Insider Monkey)
Feb-21-24 04:05PM	Ocugen to Present at 2024 BIO CEO & Investor Conference (GlobeNewswire)
Feb-20-24 10:26AM	Dear OCGN Stock Fans, Mark Your Calendars for Feb. 21 (InvestorPlace) +9.58%
Feb-14-24 07:30AM	Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024 (GlobeNewswire) +9.34%
Jan-31-24 08:00AM	Ocugen to Present at Pharma Market Research Conference (GlobeNewswire)
Jan-16-24 07:30AM	Ocugen, Inc. Announces Bob Smith Joins Business Advisory Board (GlobeNewswire) -6.43%
Dec-21-23 06:30AM	Ocugen Gains FDA Alignment on Key Aspects of OCU400 Modifier Gene Therapy Pivotal Phase 3 Study Design (GlobeNewswire) +6.86%
Dec-19-23 07:30AM	Ocugen Announces OCU400 Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Retinitis Pigmentosa Associated with RHO Mutations (GlobeNewswire) +5.83%
Dec-13-23 07:30AM	Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration (GlobeNewswire)
Nov-29-23 07:30AM	Ocugen CEO to Present at NobleCon19 Noble Capital Markets' Nineteenth Annual Emerging Growth Equity Conference (GlobeNewswire)
Nov-10-23 01:54PM	Ocugen, Inc. (NASDAQ:OCGN) Q3 2023 Earnings Call Transcript (Insider Monkey)
07:30AM	Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST Modifier Gene Therapy for Stargardt Disease (GlobeNewswire)
02:07AM	Q3 2023 Ocugen Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-09-23 11:45AM	Ocugen (OCGN) Q3 2023 Earnings Call Transcript (Motley Fool)
08:38AM	Ocugen Inc (OCGN) Reports Q3 2023 Financial Results and Business Updates (GuruFocus.com)
07:00AM	Ocugen: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Ocugen Provides Business Update with Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-07-23 07:45AM	Ocugen CSO to Participate in 4th Annual Dry AMD Therapeutic Development Summit (GlobeNewswire)
Nov-02-23 07:30AM	Ocugen to Host Conference Call on Thursday, November 9 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-10-23 09:58AM	Why Is Ocugen (OCGN) Stock Up 5% Today? (InvestorPlace) +10.27%
06:30AM	Ocugen Mucosal Vaccine Candidate OCU500 Selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials (GlobeNewswire)
Oct-04-23 07:00AM	Ocugen to Present at the 2023 Cell & Gene Meeting on the Mesa (GlobeNewswire)
Sep-29-23 07:30AM	Ocugen CSO to Participate in 4th Annual Gene Therapy for Ophthalmic Disorders Conference (GlobeNewswire)
Sep-27-23 07:30PM	Ocugen to Participate in Fireside Chat at Chardan s 7th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-21-23 07:30AM	Ocugen, Inc. Announces Connie Collingsworth Joins Business Advisory Board (GlobeNewswire)
Sep-20-23 08:00AM	Ocugen to Participate in Panel at Cantor Fitzgerald Global Healthcare Conference 2023 (GlobeNewswire)
Sep-13-23 08:15AM	Ocugen Announces Positive Clinical Study Update from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA) (GlobeNewswire)
Sep-12-23 07:30PM	Ocugen to Host Virtual Investor & Analyst Event on September 13, 2023 (GlobeNewswire)
Aug-24-23 09:48AM	Ocugen, Inc. (NASDAQ:OCGN) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-23-23 02:05AM	Q2 2023 Ocugen Inc Earnings Call (Thomson Reuters StreetEvents) +16.84%
Aug-22-23 12:00PM	Ocugen (OCGN) Q2 2023 Earnings Call Transcript (Motley Fool) -8.96%
Aug-21-23 04:32PM	Ocugen Provides Business Update with Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-18-23 04:39PM	Ocugen to Host Conference Call on Tuesday, August 22 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-25-23 08:58PM	3 Millionaire-Maker Growth Stocks to Buy Before the Window (InvestorPlace)
Jul-13-23 07:00AM	7 Biotech Stocks to Sell in July (InvestorPlace)
Jun-30-23 08:00AM	Ocugen CEO & CSO to Present at 41st Annual AAPI Convention and Scientific Assembly (GlobeNewswire)
Jun-09-23 04:05PM	Ocugen, Inc. Announces Adjournment of Annual Meeting of Shareholders (GlobeNewswire)
Jun-05-23 07:02AM	Ocugen, Inc. Announces Business Advisory Board (GlobeNewswire)
May-25-23 02:00PM	Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy? (Motley Fool)
May-24-23 08:36AM	Ocugen, Inc. Announces Pricing of $16.5 Million Public Offering of Common Stock (GlobeNewswire) -35.05%
May-23-23 04:01PM	Ocugen, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
08:00AM	Ocugen to Present at BIO International Convention 2023 (GlobeNewswire)
May-05-23 03:00PM	Ocugen (OCGN) Q1 2023 Earnings Call Transcript (Motley Fool)
07:17AM	Ocugen: Q1 Earnings Snapshot (AP Finance)
07:00AM	Ocugen Provides Business Update with First Quarter 2023 Financial Results (GlobeNewswire)
Apr-28-23 07:00AM	Ocugen to Host Conference Call on Friday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2023 Financial Results (GlobeNewswire)
Apr-27-23 07:25AM	Ocugen Announces OCU410ST Receives Orphan Drug Designation for Treatment of ABCA4-Associated Retinopathies (GlobeNewswire)
Apr-26-23 06:30AM	Ocugen, Inc. to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference (GlobeNewswire)
Apr-20-23 08:00AM	Ocugen to Present at Association for Research in Vision and Ophthalmology 2023 Annual Meeting (GlobeNewswire) -5.79%
Apr-14-23 01:47PM	Ocugen Highlights Interim Data From Gene Therapy Study For Genetic Vision Loss Disorder (Benzinga) -5.97%
07:45AM	Ocugen Announces Positive Preliminary Safety and Efficacy Results from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis (GlobeNewswire)
Apr-11-23 06:20PM	Ocugen to Host Virtual Investor & Analyst Event on April 14, 2023 (GlobeNewswire) +7.37%
Mar-31-23 08:15AM	Ocugen Chief Scientific Officer to Present at 2023 World Vaccine Congress (GlobeNewswire)
Mar-27-23 08:00AM	Ocugen Announces FDA Approval for Enrollment of Pediatric Patients in Ongoing OCU400 Phase 1/2 Clinical Trial for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA) (GlobeNewswire)
Mar-07-23 08:00AM	Ocugen, Inc. to Participate in Fireside Chat at 35th Annual Roth Conference (GlobeNewswire)
Mar-06-23 07:02AM	Ocugen Appoints Quan A. Vu to Chief Financial Officer & Chief Business Officer (GlobeNewswire) -5.49%
Mar-02-23 07:02AM	Ocugen, Inc. (NASDAQ:OCGN) Q4 2022 Earnings Call Transcript (Insider Monkey)

Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zhang Junge	Director	Jun 14 '23	Buy	0.50	200,278	99,999	1,077,182	Jun 16 04:22 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

ACVA

ACV Auctions Inc

OCGN

Ocugen Inc

Upgrade your FINVIZ experience